Search

Your search keyword '"Mayfong Mayxay"' showing total 399 results

Search Constraints

Start Over You searched for: Author "Mayfong Mayxay" Remove constraint Author: "Mayfong Mayxay"
399 results on '"Mayfong Mayxay"'

Search Results

251. Diagnosis and management of malaria by rural community health providers in the Lao People's Democratic Republic (Laos)

252. Thiamin deficiency and uncomplicated falciparum malaria in Laos

253. IN VITRO ANTIMALARIAL DRUG SUSCEPTIBILITY AND PFCRT MUTATION AMONG FRESH PLASMODIUM FALCIPARUM ISOLATES FROM THE LAO PDR (LAOS)

254. Population Structure Shapes Copy Number Variation in Malaria Parasites

255. High prevalence of Tropheryma whipplei in Lao kindergarten children

256. CHARACTERIZATION OF COUNTERFEIT ARTESUNATE ANTIMALARIAL TABLETS FROM SOUTHEAST ASIA

257. CAUSES OF COMMUNITY-ACQUIRED BACTEREMIA AND PATTERNS OF ANTIMICROBIAL RESISTANCE IN VIENTIANE, LAOS

258. Rickettsial Infections and Fever, Vientiane, Laos

259. Management of Central Nervous System Infections, Vientiane, Laos, 2003-2011.

260. A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos

261. A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better

262. List of Contributors

264. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance

266. Causes of fever in rural southern Laos

267. Genetic architecture of artemisinin-resistant Plasmodium falciparum

268. Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria

269. Bartonella henselae endocarditis in Laos - 'the unsought will go undetected'

270. Genetic variability of Plasmodium malariae dihydropteroate synthase (dhps) in four Asian countries

271. Contribution of humoral immunity to the therapeutic response in falciparum malaria

272. Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria

273. Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria

274. Thiamin supplementation does not reduce the frequency of adverse events after anti-malarial therapy among patients with falciparum malaria in southern Laos

275. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives

276. Concurrent infection with murine typhus and scrub typhus in southern Laos--the mixed and the unmixed

277. Respiratory illness healthcare-seeking behavior assessment in the Lao People’s Democratic Republic (Laos)

278. Evaluation of a rapid colorimetric field test to assess the effective life of long-lasting insecticide-treated mosquito nets in the Lao PDR

279. Elements of effective community engagement: lessons from a targeted malaria elimination study in Lao PDR (Laos)

280. The first Science Café in Laos

281. Actinomycetoma in SE Asia: the first case from Laos and a review of the literature

282. Optimal sampling designs for accurate estimation of parasite clearance in the context of artemisinin resistance

283. Health policymakers’ knowledge and opinions of physicians smoking and tobacco policy control in Lao PDR

284. A prospective assessment of the accuracy of commercial IgM ELISAs in diagnosis of Japanese encephalitis virus infections in patients with suspected central nervous system infections in Laos

285. A major genome region underlying artemisinin resistance in malaria

286. Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos

287. Multiple independent introductions of Plasmodium falciparum in South America

288. Urine antibiotic activity in patients presenting to hospitals in Laos: implications for worsening antibiotic resistance

289. Bowel obstruction from wild bananas: a neglected health problem in Laos

290. Erythrocyte Transketolase Activity, Markers of Cardiac Dysfunction and the Diagnosis of Infantile Beriberi

291. A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos

292. Genetic changes during laboratory propagation: copy number At the reticulocyte-binding protein 1 locus of Plasmodium falciparum

293. Sennetsu neorickettsiosis: a probable fish-borne cause of fever rediscovered in Laos

294. GENETIC ANALYSIS OF THE DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE GENE FROM GEOGRAPHICALLY DIVERSE ISOLATES OF PLASMODIUM MALARIAE

295. Impaired Clinical Response in a Patient with Uncomplicated Falciparum Malaria Who Received Poor-Quality and Underdosed Intramuscular Artemether

296. The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria

297. Toad poisoning in Laos

298. Combined molecular and clinical assessment of Plasmodium falciparum antimalarial drug resistance in the Lao People's Democratic Republic (Laos)

299. Contrasting genetic structure in Plasmodium vivax populations from Asia and South America

300. Diagnosis and management of malaria by rural community health providers in the Lao People's Democratic Republic (Laos)

Catalog

Books, media, physical & digital resources